Clinical Trials
6 trialsNCT07584499 2026-05-13
MRG003
Sun Yat-sen University
Phase 1 Recruiting
NCT03474640 2024-11-22
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
TopAlliance Biosciences
Phase 1 Completed
NCT03752398 2024-07-05
DUET-3
Xencor, Inc.
Phase 1 Completed
NCT05415098 2022-11-16
Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas
Ascentage Pharma Group Inc.
Phase 1 Unknown
NCT01447056 2020-02-07
MALTED
Baylor College of Medicine
Phase 1 Completed
NCT04107142 2019-09-27
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
CytoMed Therapeutics Pte Ltd
Phase 1 Unknown